2017
DOI: 10.4103/jnrp.jnrp_376_16
|View full text |Cite
|
Sign up to set email alerts
|

Isolated Intracranial Myeloid Sarcoma Occurring as Relapse in Acute Myeloid Leukemia

Abstract: Myeloid sarcoma (MS) or chloroma is a rare extramedullary tumor composed of extramedullary proliferation of blasts of granulocytic, monocytic, erythroid, or megakaryocytic lineage occurring at sites outside the bone marrow. MS occurs in 2%–8% of patients with acute myeloid leukemia (AML), sometimes it occurs as the presenting manifestation of relapse in a patient in remission. We describe the case of a young male with AML in remission for 6 years presenting with central nervous system symptoms. Magnetic resona… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…The incidence of central nervous system (CNS) involvement in MS is relatively rare, 7 accounting for only 0.4% of cases involving cranial bone marrow, vertebrae, or orbital bones. Its migration to the brain parenchyma is attributed to the disruption of the blood–brain barrier 8,9 . While orbital involvement as an initial manifestation of AML is uncommon, it is less than 3% of cases 10 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The incidence of central nervous system (CNS) involvement in MS is relatively rare, 7 accounting for only 0.4% of cases involving cranial bone marrow, vertebrae, or orbital bones. Its migration to the brain parenchyma is attributed to the disruption of the blood–brain barrier 8,9 . While orbital involvement as an initial manifestation of AML is uncommon, it is less than 3% of cases 10 .…”
Section: Discussionmentioning
confidence: 99%
“…Its migration to the brain parenchyma is attributed to the disruption of the blood–brain barrier. 8 , 9 While orbital involvement as an initial manifestation of AML is uncommon, it is less than 3% of cases. 10 In our case, brain MRI revealed a heterogeneous mass measuring 9 × 7.5 × 3 cm in the left temporal region, extending into the left sphenoid wing and causing destruction of the pilgrims.…”
Section: Discussionmentioning
confidence: 99%
“…As demonstrated in this case, APML can also less commonly form a discrete tumour mass with benign-looking radiological features (e.g. absence of vasogenic cerebral oedema or lytic bone destruction) [ 10 ]. As such, it is important to maintain a high suspicion of CNS infiltration during follow-up and reassuring radiological appearances alone should not deter from performing a lumbar puncture and CSF analysis.…”
Section: Discussionmentioning
confidence: 99%
“…9,18 The standard therapy for myeloid sarcoma involves treatment of the underlying neoplasia. 10 In adult patients with CNS involvement of AML, systemic therapy in addition to intrathecal chemotherapy and/or cranial irradiation is considered. 5 No randomized controlled trials have been performed to compare the use of these treatment modalities in patients with CNS leukemia.…”
Section: Fig 2 Comparison Of T1-weighted Mri Of the Brain From 7 Years Prior (A) And Present T1-weighted Mri Of The Brain With Gadoliniummentioning
confidence: 99%
“…To date, only a handful of case reports and small case series have described CNS myeloid sarcoma. 1,2,5,6,[9][10][11][12][13] We present a unique case of an adult male with AML in remission relapsing with an isolated, diffuse myeloid sarcoma of the cerebellum.…”
mentioning
confidence: 99%